Protecting the Aging Brain Dataset

A 7T fMRI and MRS dataset with resting state and task based data, imaged on various age cohorts, to identify the affect of aging on network connectivity.

  • Dataset S1: S1.0_Timecourse_3T_MRS_N8 (3T MRS Time-Course Study, N=8; µage=27 +/–5 years; 3 female) Using a within-participant time-locked design, as well as weight and calorie-matched dosing as per LCNeuro-PAG 3 (described below), we measured brain glucose and β-Hydroxybutyrate at baseline, and then every five minutes for 90 minutes after administering each bolus. All conditions conducted at resting-state.

    • data will be made fully available upon request.

  • Dataset S2: S2.0_Diet_7T_FMRI_N12 (7T fMRI Diet Study N=12, µage=28+/−7 years; 4 female) We scanned participants under three conditions: (1) Standard diet: following their standard diet, without fasting; (2) Fasting: following their standard diet, with an overnight (12 hour) fast; and (3) Ketogenic Diet: following a ketogenic (high-fat, moderate-protein, low-carbohydrate (<50g/day)) diet for one week, by which point all participants were in ketosis (>0.6 mmol/L ketone blood concentration). All conditions conducted at resting-state.

  • Dataset S3: S3.0_Bolus_7T_FMRI_N30 (7T fMRI Bolus Study, N=30, µage=29+/−8 years; 18 female). We scanned an independent cohort of participants under three conditions: (1) Fasting: following their standard diet, with an overnight fast; (2) Glucose Bolus: breaking the fast with a glucose drink (Glucose Tolerance Test Beverages, Fisher Scientific, Inc.; Hampton NH); and (3) D-βHb Ketone Ester Bolus: breaking the fast with a ketone drink (D-β-hydroxybutyrate ketone ester; HVMN, San Francisco CA). The D-βHb ketone ester was weight-dosed for each participant at 395mg/kg, and calorically matched (µcal=125+/−19) between D-βHb ketone ester (µKETdose=26.65g+/−3.97g) and glucose (µGLUdose=31.33g+/−4.57g). Prior to neuroimaging, we acquired fasting plasma glucose and insulin measures, for calculation of insulin resistance using HbA1c (µHbA1c=5.14%+/−0.32% [min/max=4.6-5.8%; insulin resistant >5.6%]) and HOMA-IR (µHOMA-IR=1.41+/−0.59 [min/max=0.41-2.87; insulin resistant >2.0]). HOMA-IR was calculated as: fasting insulin (µU/mL) x fasting glucose (mg/dL) /405(31). All conditions conducted at resting-state.

  • Dataset S4: S4.0_Case_7T_FMRI_N1 (7T fMRI Case Study, N=1, female, age 47, HbA1c=5.8%). For the case study, the baseline condition consisted of a standard diet supplemented 30 minutes prior to the scan with a 75g glucose bolus—a standardized challenge dose used clinically for the oral glucose tolerance test. In a time-locked within-subjects design, the participant was scanned twice: on one day with a weight-dosed (395mg/kg) 25g D-βHb ketone ester bolus and on another day without it. Each of these two conditions was conducted at resting-state and while performing spatial navigation and motor tasks.

For more information and citation, see:

Previous
Previous

Protecting the Aging Brain EEG Dataset

Next
Next

ENIGMA Dataset